… less frequent and milder grade of adverse effects. However, comparable … retrospective
study showed comparable clinical efficacy of gefitinib, erlotinib, and afatinib in Japanese patients …

… , gefitinib, erlotinib and icotinib had similar effectiveness for the … study, a network meta-analysis
was performed to compare the effectiveness and adverse effects of gefitinib, erlotinib and …

… study was aimed to compare the effectiveness and safety of erlotinib and gefitinib in
NSCLC patients… The use of EGFR inhibitors can cause some adverse drug reactions (ADRs) …

… might be administered at a lower-than-standard dose to reduce adverse events while
retaining its efficacy. In fact, retrospective studies have shown that patients who were treated with …

… analysis of studies to compare the antitumor effectiveness and adverse effects (AEs) of gefitinib
and erlotinib … dose of erlotinib down to 25 mg/day in a retrospective study and achieved a …

… adverse events for afatinib, gefitinib, and erlotinib were approximately 7%, 3%, and 2%,
respectively, in our study, … efficacy in another retrospective study [19]. It showed that there was no …

… analysis of related studies to compare the anti-tumor efficacy and adverse effects (AEs) of
gefitinib and erlotinib … In a retrospective study, Yeo reduced the erlotinib dose to 25 mg/day and …

… study was to compare the efficacies of gefitinib and erlotinib in … EGFR-mutated non-small-cell
lung cancer (NSCLC) patients. … effectiveness between gefitinib and erlotinib, this study also …

… -related adverse event and fatal adverse event in afatinib group compared to gefitinib group
(11… Moreover, other similar retrospective study performed by Krawcyzk et al. [11] showed that …

… Totally, adverse events regardless … study was designed as a retrospective analysis and
some bias could not be avoided, and the patient management was not sufficient when compared …